Pseudoaneurysm in the Mitral–Aortic Intervalvular Fibrosa—Case Report and Literature Review

Nastase, O.; Radulescu, Bogdan; Şerban, Marinela; Lăcău, Ioana Smărăndiţa; Bubenek, Şerban; Popescu, Bogdan A; Ginghină, Carmen; Jurcuţ, Ruxandra

doi:10.1111/echo.12807

Cited by 3 publications

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients with an infected pseudoaneurysm (ruptured or unruptured) may also have symptoms related to infection, in addition to chest pain, dyspnea, and cerebrovascular events. 28,29 Other rare symptoms may be caused by mechanical obstruction or compression of the conduction system or coronary arteries, which are unusual causes of heart block and ischemia. 30 UARP should be surgically repaired if it is associated with significant symptoms or is rapidly enlarging.…”

Section: Discussionmentioning

confidence: 99%

Transcatheter aortic valve implantation in patients with unruptured aortic root pseudoaneurysm: an observational study

Chiocchi

Pugliese

D’Errico

et al. 2021

Journal of Cardiovascular Medicine

View full text Add to dashboard Cite

Aims Unruptured aortic root pseudoaneurysm (UARP) is a rare complication of aortic valve endocarditis. Infectious spread to the valvular annulus or myocardium can cause septic complications that manifest as wall thickening, and spontaneous abscess drainage leads to pseudoaneurysm formation. We report the first patient series in which transcatheter aortic valve implantation (TAVI) using a single valve-resolved aortic valvulopathy associated with UARP was performed.Methods At our center, from December 2017 to October 2019, 138 patients underwent TAVI for aortic valve stenosis and/or regurgitation, 20 of whom (12 female patients, 8 male patients) had associated incidental UARP and were considered as our study population. The average age of these patients was 76.9 W 5.2 years. All patients were assessed using preprocedural and postprocedural multimodality imaging, including transthoracic echocardiography, transesophageal echocardiography, and cardiac computed tomography angiography (CCTA).Results In all cases, the final angiographic examination showed correct valve positioning with complete coverage of the false aneurysm. Post-TAVI CCTA showed presence of total or subtotal UARP thrombosis. The mean follow-up period was 17.5 months (12-23 months). During follow-up, imaging showed normal prosthetic valve function, no significant leakage (trace or mild), and complete UARP exclusion in all patients, without any complications. ConclusionIn conclusion, percutaneous valve positioning can simultaneously solve pseudoaneurysm complications by excluding the sac and promoting thrombosis.

show abstract

Section: Discussionmentioning

confidence: 99%